Journals / Göğüs Kalp Damar Anestezi ve Yoğun Bakım Derneği Dergisi / 2016 / Cilt: 22 - Sayı: 4

Our Anesthesia Experience With Patients who Underwent Transcatheter Aortic Valve Replacement

Kliniğimizde Transkateter Aort Replasmanı Yapılan Hastalarda Anestezi Deneyimimiz

Pages
145–151
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The growing experience in TAVR procedures will result in increased procedure success rates.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Valvular aortic stenosis (AS) is a major cardiac valvular disease in geriatric patients.
📊
Key Findings & Data:Material and Method: Sixty-seven patients with serious symptomatic AS (29 male, 38 female, mean age 78.3±6.44 years) undergoing TAVR procedure under GA were evaluated retrospectively and included in this study.Results: The mean durations of the procedure and anesthesia were 159±38 min and 193±41 min, respectively.
💡
Conclusion & Impact:The growing experience in TAVR procedures will result in increased procedure success rates.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Valvular aortic stenosis (AS) is a major cardiac valvular disease in geriatric patients. The conventional therapy for serious AS is surgical aortic valve replacement. But most of the geriatric patients are considered to be non-operable due to anesthetical and surgical high risks. Recently, transcatheter aortic valve replacement (TAVR) is rapidly evolving new alternative therapy option for these high risk AS patients. In this study, we aimed to share our experience in patients undergoing TAVR procedure under general anesthesia (GA). Material and Method: Sixty-seven patients with serious symptomatic AS (29 male, 38 female, mean age 78.3±6.44 years) undergoing TAVR procedure under GA were evaluated retrospectively and included in this study.Results: The mean durations of the procedure and anesthesia were 159±38 min and 193±41 min, respectively. A total of 28 (41%) patients underwent blood transfusions. Vasopressor drugs were infused to 4 (0.5%) patients intraoperatively The median stay of intensive care unit and hospital stay stay were 2 , and 7 days, respectively.Conclusion: TAVR is a challeging procedure for anesthesiologists due to the complexity of the procedure itself and also the high risk carried by the patient population who will undergo TAVR. Anesthesiologists have to ensure hemodynamic stability, and to protect the vital functions. Optimal perioperative evaluation is important for rapid and safe approach to possible complications. The growing experience in TAVR procedures will result in increased procedure success rates.

Özet

Amaç: Aort kapak darlığı geriyatrik hastalarda major bir kardiyak kapak hastalığıdır. Şiddetli aort kapak darlığı için konvansiyonel tedavi seçeneği, cerrahi girişim ile aortik kapak replasmanıdır. Ancak çoğu geriyatrik hasta cerrahi ve anestezi açısından yüksek risk nedeniyle opere edilemez olarak kabul edilir. Transkateter aortik kapak replasmanı (TAVR) yüksek riskli aort kapak darlığı olan hastalarda son yıllarda hızla gelişen bir alternatif tedavi seçeneğidir. Bu çalışmada, genel anestezi altında TAVR prosedürü uygulanan hastalardaki anestezi deneyimimizi paylaşmayı amaçladık. Gereç ve Yöntem: Çalışmaya Ocak 2014-Haziran 2016 tarihleri arasında semptomatik ciddi aort darlığı olup, genel anestezi altında TAVR uygulanan 67 hasta (29 erkek, 38 kadın, yaş ortalaması 78±6) retrospektif olarak değerlendirildi. Bulgular: Genel anestezi uygulanan 67 hastada toplam işlem süresi 159.1±38.97 dk., anestezi süresi ise 193±41 dk. idi. Toplam 28 hastaya kan transfüzyonu yapıldı (%41). Dört hastada intraoperatif dönemde vazopressör infüzyonu başlandı (%5.9). Bu hastaların yoğun bakımda kalış süresi 2 gün, hastanede kalış süresi 7 gündü. Sonuç: TAVR uygulaması, hem uygulanan prosedürün karmaşıklığı hem de uygulanan hasta popülasyonunun yüksek risk taşıyan hastalar olması nedeniyle anestezistler için oldukça zorlu bir girişimdir. Anestezist, hastanın vital fonksiyonlarının korunması amacıyla hemodinamik stabiliteyi sağlamak durumundadır. Preoperatif iyi bir değerlendirme olası komplikasyonlara daha hızlı ve güvenli bir yaklaşım için önemlidir. TAVR prosedürü ile ilgili deneyimlerin artması, işlemin başarısının da artmasıyla sonuçlanacaktır.

🔖

Cite This Article

GÜRCÜ, M. E., GÜZELMERİÇ, F., ERKILINÇ, A., ŞAVLUK, Ö. F., BİNGÖLBALİ, M. E., ÇEVİRME, D., GÜLER, A., İZGİ, A., KIRMA, C., GÜLER, C. (2016). Our Anesthesia Experience With Patients who Underwent Transcatheter Aortic Valve Replacement. Göğüs Kalp Damar Anestezi ve Yoğun Bakım Derneği Dergisi, Cilt: 22 - Sayı: 4, 145–151. https://ajindex.com/articles/173431

References (11)

  1. Iung B. Management of the elderly patient with aortic stenosis. Heart 2008;94:519-24.
  2. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005;111:3316-26.
  3. Brown JM, O'Brien SM, Wu C, et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 2009;137:82-90.
  4. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur. Heart J 2003; 24:1231-43.
  5. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8.
  6. Hannan EL, Samadashvili Z, Stamato NJ, Lahey SJ, Wechsler A, Jordan D, et al. Utilization and 1-year mortality for transcatheter aortic valve replacement and surgical aortic valve replacement in New York patients with aortic stenosis: 2011 to 2012. JACC Cardiovasc Interv 2016;9:578-85.
  7. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012). European Heart Journal 2012;33(19):2451-96.
  8. Ata Hassani Afshar, Pourafkari L, Nader D. Periprocedural considerations of transcatheter aortic valve implantation for anesthesiologists. J Cardiovasc Trac Res 2016;8(2):49-55.
  9. Fröhlich GM, Lansky AJ, Webb J, et al. Local versus general anesthesia for transcatheter aortic valve implantation (TAVR) - system- atic review and meta-analysis. BMC Med 2014;12:41.
  10. Fassl J, Walther T, Groesdonk HV, Kempfert J, Borger MA, Scholz M, et al. Anesthesia management for transapical transcatheter aortic valve implantation: a case series. J Cardiothorac Vasc Anesth 2009;23:286-91.
  11. Christ M, Sharkova Y, Geldner G, Mai